Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page

  1. Check
    12 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2. No study data or user-facing content is affected.
    Difference
    0.0%
    Check dated 2026-02-13T07:55:07.000Z thumbnail image
  2. Check
    19 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1 and no longer displays Revision: v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-05T14:36:37.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    Added a glossary display option and updated metadata to Revision: v3.4.0, including Last Update Submitted that Met QC Criteria and No FEAR Act Data. Removed the previous QC-related labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-29T09:43:36.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T02:51:47.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing study sites across multiple regions (US, Australia, Canada, Taiwan, Spain) and removed the old per-country location blocks. The update reorganizes site information on the page to streamline finding participating sites.
    Difference
    1%
    Check dated 2025-12-24T14:56:54.000Z thumbnail image
  6. Check
    91 days ago
    Change Detected
    Summary
    PubMed data source text was updated to indicate that publications are automatically filled from PubMed. The page revision version was updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T14:56:40.000Z thumbnail image

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.